The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease.
Complementary DNAs (cDNAs) encoding portions of the amyloid beta protein were used to investigate possible amyloid gene duplication in sporadic Alzheimer's disease. A strategy employing two Eco RI restriction fragment length polymorphisms (RFLPs) detected by the amyloid cDNAs was used. RFLPs allow the detection of a 2:1 gene dosage in the DNA of any individual who is heterozygous for a particular RFLP. The amyloid gene regions homologous to the cDNAs used were not duplicated in the DNA from brains of individuals with sporadic Alzheimer's disease. Similar results were also obtained with a strategy employing a test for 3:2 gene dosage.
D000483:Alleles; D000544:Alzheimer Disease / Q000235:genetics*; D000682:Amyloid / Q000235:genetics*; D016229:Amyloid beta-Peptides; D002886:Chromosomes, Human, Pair 17; D002891:Chromosomes, Human, Pair 21; D004247:DNA / Q000235:genetics; D005796:Genes; D006801:Humans; D008869:Microtubule-Associated Proteins / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length; D016875:tau Proteins
D000682:Amyloid; D016229:Amyloid beta-Peptides; D008869:Microtubule-Associated Proteins; D016875:tau Proteins; D004247:DNA